Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
PLoS One
2014 Jan 01;91:e86089. doi: 10.1371/journal.pone.0086089.
Show Gene links
Show Anatomy links
ARP2, a novel pro-apoptotic protein expressed in epithelial prostate cancer LNCaP cells and epithelial ovary CHO transformed cells.
Mas-Oliva J
,
Navarro-Vidal E
,
Tapia-Vieyra JV
.
???displayArticle.abstract???
Neoplastic epithelial cells generate the most aggressive types of cancers such as those located in the lung, breast, colon, prostate and ovary. During advanced stages of prostate cancer, epithelial cells are associated to the appearance of androgen-independent tumors, an apoptotic-resistant phenotype that ultimately overgrows and promotes metastatic events. We have previously identified and electrophysiologically characterized a novel Ca(2+)-permeable channel activated during apoptosis in the androgen-independent prostate epithelial cancer cell line, LNCaP. In addition, we reported for the first time the cloning and characterization of this channel-like molecule named apoptosis regulated protein 2 (ARP2) associated to a lethal influx of Ca(2+) in Xenopus oocytes. In the present study, LNCaP cells and Chinese hamster ovary cells (CHO cell line) transfected with arp2-cDNA are induced to undergo apoptosis showing an important impact on cell viability and activation of caspases 3 and 7 when compared to serum deprived grown cells and ionomycin treated cells. The subcellular localization of ARP2 in CHO cells undergoing apoptosis was studied using confocal microscopy. While apoptosis progresses, ARP2 initially localized in the peri-nuclear region of cells migrates with time towards the plasma membrane region. Based on the present results and those of our previous studies, the fact that ARP2 constitutes a novel cation channel is supported. Therefore, ARP2 becomes a valuable target to modulate the influx and concentration of calcium in the cytoplasm of epithelial cancer cells showing an apoptotic-resistant phenotype during the onset of an apoptotic event.
???displayArticle.pubmedLink???
24465888
???displayArticle.pmcLink???PMC3899214 ???displayArticle.link???PLoS One
Figure 2. ARP2 expression induces apoptosis in CHO cells.(A) Western blots detected expression of β-gal-V5 (112 kDa) and ARP2-V5 (54 kDa) in total cell lysates. (B) Normalized cell viability% of controls was assessed using MTT assays with 2×104 cells cultured in the absence of serum or transfected with arp2 cDNA. Viability of these two treatment groups were assayed at 16, 24, 48, and 72 h timepoints. (C) Normalized cell viability% of controls was assessed using a trypan blue exclusion method. Cells were cultured in the absence of serum or transfected with arp2 cDNA and assayed at 16, 24, 48, and 72 h timepoints. Mean values are presented (n = 3, X ± S.E.M), #p<0.05, *p<0.01, ¶p<0.001, compared to control groups.
Figure 3. Activity of caspases 3 and 7.Caspase activity was determined using a fluorometric assay employing Z-DEVD-AFC as a substrate. (A) CHO cells grown in the absence of serum, transfected with arp2 cDNA or incubated with 10 µM ionomycin assayed at 16, 24, 48 and 72 h timepoints. (B) LNCaP cells grown in the absence of serum, transfected with arp2 cDNA (72 h) or incubated with 10 µM ionomycin assayed at 16, 24, 48 and 72 h timepoints. Mean values are presented (n = 3, X ± S.E.M), #p<0.05, *p<0.01, ¶p<0.001 compared to control groups.
Figure 4. Confocal microscopy of ARP2 fusion protein expressed in CHO cells.CHO cells transfected with egfp cDNA were observed 24 h post-transfection using confocal microscopy (A) and DIC microscopy (B). CHO cells transfected with arp2-egfp cDNA were also observed 24 h post-transfection using confocal microscopy (C) and DIC microscopy (D). Scale bar 50 µm. White arrows indicate cells that present ARP2 localized to the peri-nuclear region.
Figure 5. Confocal microscopy of ARP2 fusion protein expressed in CHO cells.CHO cells transfected with arp2-egfp cDNA examined at 16, 24, 48 and 72 h post-transfection (A, C, E and G respectively). Same using DIC microscopy (B, D, F and H respectively). Scale bar 10 µm.
Figure 1. ARP2 expression induces apoptosis in LNCaP cells.(A) Western blots detected expression of β-gal-V5 (112 kDa) and ARP2-V5 (54 kDa) in total cell lysates. (B) Normalized cell viability% of controls was assessed using MTT assays with 2×104 cells cultured in the absence of serum or transfected with arp2 cDNA. Viability of these two treatment groups were assayed at 16, 24, 48, and 72 h timepoints. (C) Normalized cell viability% of controls assayed using a trypan blue exclusion method. Cells were cultured in the absence of serum or transfected with arp2 cDNA and assayed at 16, 24, 48, 72, 96, and 120 h timepoints. Mean values are presented (n = 3, X ± S.E.M), #
p<0.05, *p<0.01, ¶
p<0.001 compared to control groups.
Antonarakis,
Novel targeted therapeutics for metastatic castration-resistant prostate cancer.
2010,
Pubmed
Berridge,
Capacitative calcium entry.
1995,
Pubmed
Bruckheimer,
Implications of cell death regulation in the pathogenesis and treatment of prostate cancer.
1999,
Pubmed
Bursch,
Cell death by apoptosis and its protective role against disease.
1992,
Pubmed
Chen,
Initiator caspases in apoptosis signaling pathways.
2002,
Pubmed
Chung,
New targets for therapy in prostate cancer: modulation of stromal-epithelial interactions.
2003,
Pubmed
Chung,
Prostate epithelial differentiation is dictated by its surrounding stroma.
1996,
Pubmed
Cohen,
Apoptosis.
1993,
Pubmed
Degterev,
Identification of RIP1 kinase as a specific cellular target of necrostatins.
2008,
Pubmed
Dutta,
Neoadjuvant chemotherapy for epithelial ovarian cancer--role of apoptosis.
2005,
Pubmed
Evan,
Proliferation, cell cycle and apoptosis in cancer.
2001,
Pubmed
Flourakis,
Orai1 contributes to the establishment of an apoptosis-resistant phenotype in prostate cancer cells.
2010,
Pubmed
Green,
Mitochondria and apoptosis.
1998,
Pubmed
Grynkiewicz,
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
1985,
Pubmed
Gutierrez,
Activation of a Ca2+-permeable cation channel by two different inducers of apoptosis in a human prostatic cancer cell line.
1999,
Pubmed
Hengartner,
The biochemistry of apoptosis.
2000,
Pubmed
Hirst,
Measurement of [Ca2+]i in whole cell suspensions using fura-2.
2006,
Pubmed
Hoffman,
Molecular controls of apoptosis: differentiation/growth arrest primary response genes, proto-oncogenes, and tumor suppressor genes as positive & negative modulators.
1994,
Pubmed
Hoskins,
The spliceosome: a flexible, reversible macromolecular machine.
2012,
Pubmed
Isaacs,
The biology of hormone refractory prostate cancer. Why does it develop?
1999,
Pubmed
Jürgensmeier,
Bax directly induces release of cytochrome c from isolated mitochondria.
1998,
Pubmed
Kerr,
Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics.
1972,
Pubmed
Lepor,
The influence of hormonal therapy on survival of men with advanced prostatic cancer.
1982,
Pubmed
Lopaczynski,
Preprostatectomy: A clinical model to study stromal-epithelial interactions.
2001,
Pubmed
Luo,
The human Prp8 protein is a component of both U2- and U12-dependent spliceosomes.
1999,
Pubmed
Majno,
Apoptosis, oncosis, and necrosis. An overview of cell death.
1995,
Pubmed
Martikainen,
Programmed death of nonproliferating androgen-independent prostatic cancer cells.
1991,
Pubmed
McCaffrey,
Epithelial organization, cell polarity and tumorigenesis.
2011,
Pubmed
Negoescu,
Apoptosis in cancer: therapeutic implications.
2000,
Pubmed
Nicotera,
Calcium-mediated mechanisms in chemically induced cell death.
1992,
Pubmed
O'Connor,
Apoptosis and cell division.
2000,
Pubmed
Orfanelli,
Identification of novel sense and antisense transcription at the TRPM2 locus in cancer.
2008,
Pubmed
Orrenius,
Regulation of cell death: the calcium-apoptosis link.
2003,
Pubmed
Parekh,
Store depletion and calcium influx.
1997,
Pubmed
Peehl,
Primary cell cultures as models of prostate cancer development.
2005,
Pubmed
Pigozzi,
Calcium store contents control the expression of TRPC1, TRPC3 and TRPV6 proteins in LNCaP prostate cancer cell line.
2006,
Pubmed
Prevarskaya,
Ca2+ homeostasis in apoptotic resistance of prostate cancer cells.
2004,
Pubmed
Prevarskaya,
TRP channels in cancer.
2007,
Pubmed
Raff,
Social controls on cell survival and cell death.
1992,
Pubmed
Savill,
Phagocyte recognition of cells undergoing apoptosis.
1993,
Pubmed
Skryma,
Store depletion and store-operated Ca2+ current in human prostate cancer LNCaP cells: involvement in apoptosis.
2000,
Pubmed
Steller,
Mechanisms and genes of cellular suicide.
1995,
Pubmed
Sung,
Prostate tumor-stroma interaction: molecular mechanisms and opportunities for therapeutic targeting.
2002,
Pubmed
Tapia-Vieyra,
ARP2 a novel protein involved in apoptosis of LNCaP cells shares a high degree homology with splicing factor Prp8.
2005,
Pubmed
,
Xenbase
Tapia-Vieyra,
Apoptosis and cell death channels in prostate cancer.
2001,
Pubmed
Thompson,
Apoptosis in the pathogenesis and treatment of disease.
1995,
Pubmed
Turner,
Dissection of Prp8 protein defines multiple interactions with crucial RNA sequences in the catalytic core of the spliceosome.
2006,
Pubmed
Vanden Abeele,
Bcl-2-dependent modulation of Ca(2+) homeostasis and store-operated channels in prostate cancer cells.
2002,
Pubmed
Vanoverberghe,
Ca2+ homeostasis and apoptotic resistance of neuroendocrine-differentiated prostate cancer cells.
2004,
Pubmed
Vaux,
The molecular biology of apoptosis.
1996,
Pubmed
Wes,
TRPC1, a human homolog of a Drosophila store-operated channel.
1995,
Pubmed
Williams,
Programmed cell death: apoptosis and oncogenesis.
1991,
Pubmed
Williams,
Molecular regulation of apoptosis: genetic controls on cell death.
1993,
Pubmed
Wu,
Stromal cell heterogeneity in fibroblast growth factor-mediated stromal-epithelial cell cross-talk in premalignant prostate tumors.
2003,
Pubmed
Xu,
Coassembly of TRP and TRPL produces a distinct store-operated conductance.
1997,
Pubmed
Yuan,
Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.
2006,
Pubmed
Zhu,
trp, a novel mammalian gene family essential for agonist-activated capacitative Ca2+ entry.
1996,
Pubmed